HOME >> MEDICINE >> NEWS
Doctors don't agree on diagnosis of uterine cancer

A Gynecologic Oncology Group (GOG) study, headed by Cornelia Trimble, M.D. of the Johns Hopkins Kimmel Cancer Center, has revealed that pathologists who evaluate uterine biopsies disagree 60 percent of the time on whether the specimens contain cancerous cells. The authors, expected to present their findings at the 40th annual American Society of Clinical Oncology, say new standards for collecting and classifying biopsies are needed to improve the accuracy of diagnoses.

Cancer of the uterus is the most common cancer affecting the female reproductive tract in the United States. It is diagnosed from biopsied uterine or endometrial cells that indicate the presence of cancer or precancerous lesions called atypical endometrial hyperplasia (AEH).

"This study brought into sharp focus the fact that it is very difficult to make an accurate diagnosis from uterine biopsies," says Trimble, associate professor at the Johns Hopkins Kimmel Cancer Center. " Yet, women receiving a diagnosis of AEH face complete removal of their wombs through hysterectomy. So, we suggest these patients get a second opinion from a pathologist who specializes in gynecology ."

Trimble and colleagues in the national cooperative GOG set out to get a baseline estimate of the percentage of actual cancers found in hysterectomy samples of women diagnosed with AEH biopsies. The baseline, reported to be anywhere from 17 to 52 percent, would provide information needed to design studies to find non-surgical treatments for AEH that preserve fertility in young patients or eliminate the need for surgery in women with diabetes, hypertension or other complicating disorders. But, after reviewing biopsies from 289 patients classified as AEH, they were surprised to find a high degree of disagreement with the initial diagnosis of most of the biopsies.

In their review, the GOG investigators downgraded the biopsy diagnoses to "less than AEH," which denotes a
'"/>

Contact: Vanessa Wasta
wastava@jhmi.edu
410-955-1287
Johns Hopkins Medical Institutions
2-Jun-2004


Page: 1 2

Related medicine news :

1. Doctors need to prepare for blood shortages now
2. Doctors must consider potentially inappropriate medications when treating elderly
3. Doctors transplant ovary to womans arm to preserve fertility
4. Doctors can improve colorectal cancer screening rates
5. Doctors miss chances to provide diet, exercise counseling to patients at risk of heart disease
6. Doctors and patients call on politicians to save lives of cancer patients
7. Doctors at Northwestern Memorial are studying next generation surgery for back pain sufferers
8. U-M study: Doctors more likely to prescribe pricey new blood pressure drugs
9. Doctors over-estimate survival of terminally ill patients
10. Doctors are often strongly affected by patient deaths
11. Doctors have feelings, too

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Doctors don agree diagnosis uterine cancer

(Date:5/24/2013)... News) -- Drugs commonly used to treat glaucoma may ... interfere with vision, according to a new study. ... used to reduce eye pressure, have already been shown ... color, the researchers said, suggesting that the new findings ... Doctors should be conservative when prescribing these drugs, the ...
(Date:5/24/2013)... Let’s face it: very few are luckily ... the majority of people to be uncomfortable with the color ... coffee addiction or simply genetics, yellowish or stained teeth suppresses ... , Herald Square Dental is proud to announce ... Venus White Max. , Teeth become discolored for a ...
(Date:5/24/2013)... Chino, CA (PRWEB) May 24, 2013 Area ... huge selection of new hot tubs to choose from at ... Super Sale . The sales event takes place at ... May 26, 2013. , Jacuzzi, the industry's leading hot ... sale traveling across the country. The event will feature popular ...
(Date:5/24/2013)... New York (PRWEB) May 24, 2013 ... lawsuit involving Intuitive Surgical Inc.’s da Vinci Surgical ... to court records, a Washington State Court jury ruled ... negligence in training a surgeon who performed a da ... later. The patient’s family had alleged in their ...
(Date:5/24/2013)... development of infantile myofibromatosis (IM)a disorder characterized by multiple ... new therapeutic targets, according to researchers from the Icahn ... in the American Journal of Human Genetics , ... disease, for which the only current treatment option is ... an inheritied disorder that develops in infancy or even ...
Breaking Medicine News(10 mins):Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2Health News:Herald Square Dental Introduces New In-office Whitening System: Venus White Max 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 3Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2
(Date:5/23/2013)... SAN DIEGO y PARÍS, 24 de ... VOLC ), un destacado desarrollador y fabricante ... para mejorar la diagnosis y tratamiento de la ... resultados preliminares del ensayo ADVISE ( Ad enosine ... tenosis E valuation) II durante la sesión ...
(Date:5/23/2013)... , May 23, 2013 Amgen (NASDAQ: ... th Annual  Healthcare Conference on Thursday, May 30, 2013, ... , beginning at 9:20 a.m. Eastern Daylight Time. ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
(Date:5/23/2013)... , May 23, 2013 Nephros, Inc. ... stage medical device company that develops and sells high ... of its rights offering.  In addition, the concurrent temporary ... warrants expired on May 17, 2013. Nephros ... million from the rights offering.   A portion of the ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
Cached News: